Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Non Operating Investment Income (2025)

Camp4 Therapeutics (CAMP) has disclosed Non Operating Investment Income for 1 consecutive years, with -$28.0 million as the latest value for Q4 2025.

  • Quarterly Non Operating Investment Income changed N/A to -$28.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$29.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$29.8 million for FY2025, N/A changed from the prior year.
  • Non Operating Investment Income hit -$28.0 million in Q4 2025 for Camp4 Therapeutics, down from -$1.8 million in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of -$1.8 million in Q3 2025 to a low of -$28.0 million in Q4 2025.